# Adaptive Optics Imaging of Outer Retinal Diseases

> **NCT05355415** · — · RECRUITING · sponsor: **Food and Drug Administration (FDA)** · enrollment: 100 (estimated)

## Conditions studied

- Retinal Degeneration
- Age-Related Macular Degeneration
- Retinitis Pigmentosa
- Hydroxychloroquine Retinopathy
- Usher Syndromes
- Late-Onset Retinal Degeneration
- Cone Dystrophy
- Cone Rod Dystrophy
- Rod Cone Dystrophy
- Rod Dystrophy

## Interventions

- **DEVICE:** Adaptive optics imaging

## Key facts

- **NCT ID:** NCT05355415
- **Lead sponsor:** Food and Drug Administration (FDA)
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-27
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05355415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05355415, "Adaptive Optics Imaging of Outer Retinal Diseases". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05355415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*